News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GARCEAU ROGER
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| GARCEAU ROGER (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.85, valued at
$28.5k
|
|
| 01/04/2023 |
4
| GARCEAU ROGER (Director) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Granted 89,041 options to buy
@ $0.73, valued at
$65k
|
|
| 06/09/2022 |
4
| GARCEAU ROGER (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.5, valued at
$35k
|
|
| 01/11/2022 |
4
| GARCEAU ROGER (Director) has filed a Form 4 on Entera Bio Ltd.|
Txns:
| Granted 35,852 options to buy
@ $2.815, valued at
$100.9k
Granted 107,557 options to buy
@ $2.815, valued at
$302.8k
|
|
| 01/11/2022 |
3
| GARCEAU ROGER (Director) has filed a Form 3 on Entera Bio Ltd. |
| 06/10/2021 |
4
| GARCEAU ROGER (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $10.51, valued at
$105.1k
|
|
| 06/11/2020 |
4
| GARCEAU ROGER (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 9,000 options to buy
@ $35, valued at
$315k
|
|
| 06/11/2020 |
4/A
| GARCEAU ROGER (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 12,399 options to buy
@ $9.18, valued at
$113.8k
|
|
| 01/13/2020 |
4
| GARCEAU ROGER (Director) has filed a Form 4 on ArTara Therapeutics, Inc.|
Txns:
| Granted 33,000 shares
@ $0
Granted 12,399 options to buy
@ $9.18, valued at
$113.8k
Granted 10,491 options to buy
@ $9.18, valued at
$96.3k
|
|
| 01/13/2020 |
3
| GARCEAU ROGER (Director) has filed a Form 3 on ArTara Therapeutics, Inc. |
| 02/24/2015 |
4
| GARCEAU ROGER (SVP & CMO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 43,349 shares
@ $46, valued at
$2M
Disposed/sold 30,615 options to buy
@ $38.27, valued at
$1.2M
Disposed/sold 84,941 options to buy
@ $8.23, valued at
$699.1k
Disposed/sold 9,900 options to buy
@ $8.21, valued at
$81.3k
Disposed/sold 25,179 options to buy
@ $8.25, valued at
$207.7k
Disposed/sold 25,998 options to buy
@ $3.34, valued at
$86.8k
Disposed/sold 10,905 restricted stock units
@ $0
Disposed/sold 7,665 restricted stock units
@ $0
Disposed/sold 10,531 restricted stock units
@ $0 |
|
| 02/20/2015 |
4
| GARCEAU ROGER (SVP & CMO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Acquired 15,168 shares
@ $0
Paid exercise price by delivering 5,438 shares
@ $45.85, valued at
$249.3k
Paid exercise price by delivering 1,564 shares
@ $45.85, valued at
$71.7k
Paid exercise price by delivering 5,460 shares
@ $45.88, valued at
$250.5k
Exercised 3,832 restricted stock units
@ $0
Granted 10,905 restricted stock units
@ $0
Exercised 10,531 restricted stock units
@ $0 |
|
| 02/12/2015 |
4
| GARCEAU ROGER (SVP &CMO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Gifted 11,000 shares
@ $0 |
|
| 02/09/2015 |
4
| GARCEAU ROGER (SVP & CMO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Exercised 15,384 shares
@ $45.88, valued at
$705.8k
|
|
| 02/14/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/11/2014 |
4
| GARCEAU ROGER (SVP & CMO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Acquired 15,167 shares
@ $0
Paid exercise price by delivering 5,371 shares
@ $35.13, valued at
$188.7k
|
|
| 01/09/2014 |
4
| GARCEAU ROGER (SVP & CMO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 15,000 options
@ $3.34, valued at
$50.1k
|
|
| 09/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/21/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/15/2013 |
4
| GARCEAU ROGER (SVP & CMO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 84,941 options to buy
@ $8.23, valued at
$699.1k
Granted 31,592 restricted stock units
@ $0 |
|
| 02/11/2013 |
4
| GARCEAU ROGER (SVP & CMO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Acquired 15,165 shares
@ $0
Paid exercise price by delivering 5,586 shares
@ $8.61, valued at
$48.1k
|
|
| 12/21/2012 |
4
| GARCEAU ROGER (SVP & CMO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 80,000 options
@ $3.34, valued at
$267.2k
|
|
| 10/05/2012 |
4
| GARCEAU ROGER (SVP & CMO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Sold 140,625 shares
@ $9.5084, valued at
$1.3M
Exercised 140,625 options
@ $5.98, valued at
$840.9k
|
|
| 02/01/2012 |
4
| GARCEAU ROGER (SVP & CMO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 40,000 options
@ $3.34, valued at
$133.6k
|
|
| 02/22/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/23/2010 |
4
| GARCEAU ROGER (SVP & CMO) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 55,000 options
@ $3.34, valued at
$183.7k
Granted 27,500 restricted stock units
@ $0 |
|
| 12/12/2008 |
4
| GARCEAU ROGER (SVP & CMO) has filed a Form 4 on NPS PHARMACEUTICALS INC |
| 12/12/2008 |
3
| GARCEAU ROGER (SVP & CMO) has filed a Form 3 on NPS PHARMACEUTICALS INC |
|
|